Last 7 days
-1.5%
Last 30 days
5.5%
Last 90 days
2.2%
Trailing 12 Months
20.6%
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2023 | 13.0B | 13.4B | 13.8B | 0 |
2022 | 12.2B | 12.3B | 12.6B | 12.7B |
2021 | 10.1B | 11.2B | 11.5B | 11.9B |
2020 | 10.8B | 10.2B | 10.1B | 9.9B |
2019 | 9.9B | 10.1B | 10.4B | 10.7B |
2018 | 9.3B | 9.5B | 9.7B | 9.8B |
2017 | 8.6B | 8.7B | 8.8B | 9.0B |
2016 | 7.7B | 8.0B | 8.2B | 8.4B |
2015 | 7.4B | 7.3B | 7.4B | 7.5B |
2014 | 7.2B | 7.2B | 7.3B | 7.4B |
2013 | 7.1B | 7.1B | 7.1B | 7.1B |
2012 | 7.6B | 7.4B | 7.3B | 7.2B |
2011 | 7.8B | 7.8B | 7.8B | 7.6B |
2010 | 8.1B | 8.0B | 7.9B | 7.8B |
2009 | 8.0B | 8.1B | 8.1B | 8.2B |
2008 | 8.3B | 8.2B | 8.1B | 8.1B |
2007 | 0 | 0 | 0 | 8.4B |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Dec 03, 2023 | mirviss jeffrey b. | acquired | - | - | 649 | evp&pres, periph intervent |
Dec 03, 2023 | mirviss jeffrey b. | sold (taxes) | -16,617 | 56.14 | -296 | evp&pres, periph intervent |
Nov 20, 2023 | butcher arthur c | sold | -447,509 | 54.06 | -8,278 | evp& grp pres, medsurg & apac |
Nov 20, 2023 | butcher arthur c | acquired | 66,606 | 17.26 | 3,859 | evp& grp pres, medsurg & apac |
Nov 15, 2023 | carruthers wendy | sold | -632,269 | 54.1744 | -11,671 | evp, human resources |
Nov 15, 2023 | carruthers wendy | acquired | 94,953 | 14.818 | 6,408 | evp, human resources |
Nov 08, 2023 | mirviss jeffrey b. | gifted | - | - | -4,000 | evp&pres, periph intervent |
Nov 06, 2023 | mahoney michael f | sold | -5,951,980 | 52.507 | -113,356 | chairman, president & ceo |
Nov 06, 2023 | mahoney michael f | acquired | 1,662,530 | 14.6664 | 113,356 | chairman, president & ceo |
Oct 16, 2023 | carruthers wendy | sold | -581,063 | 49.7869 | -11,671 | evp, human resources |
Datesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
Dec 06, 2023 | Raleigh Capital Management Inc. | added | 3.74 | 2,096 | 166,908 | 0.09% |
Dec 06, 2023 | CITIGROUP INC | added | 2.5 | 70,409 | 122,224,000 | 0.09% |
Dec 04, 2023 | Phoenix Holdings Ltd. | added | 85.77 | 6,402,050 | 14,188,700 | 0.13% |
Dec 04, 2023 | TUCKER ASSET MANAGEMENT LLC | added | 53.12 | 856 | 2,587 | -% |
Dec 01, 2023 | B. Riley Wealth Advisors, Inc. | reduced | -60.79 | -1,385,300 | 859,056 | 0.02% |
Nov 28, 2023 | ASB Consultores, LLC | sold off | -100 | -292,519 | - | -% |
Nov 28, 2023 | IMA Wealth, Inc. | reduced | -1.59 | -70,053 | 1,707,180 | 0.44% |
Nov 27, 2023 | OKABENA INVESTMENT SERVICES INC | sold off | -100 | -16,822 | - | -% |
Nov 27, 2023 | BANQUE PICTET & CIE SA | reduced | -12.27 | -3,619,040 | 21,573,900 | 0.26% |
Nov 27, 2023 | TRUST CO OF VERMONT | added | 43.51 | 69,172 | 241,719 | 0.02% |
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Feb 14, 2023 | blackrock inc. | 9.6% | 137,802,646 | SC 13G/A | |
Feb 09, 2023 | fmr llc | - | 0 | SC 13G/A | |
Feb 09, 2023 | vanguard group inc | 8.29% | 118,773,794 | SC 13G/A | |
Feb 08, 2023 | massachusetts financial services co /ma/ | 5.8% | 82,467,469 | SC 13G/A | |
Feb 06, 2023 | wellington management group llp | 4.03% | 57,736,340 | SC 13G/A | |
Jan 24, 2023 | blackrock inc. | 9.8% | 140,116,265 | SC 13G/A | |
Feb 09, 2022 | vanguard group inc | 7.83% | 111,621,630 | SC 13G/A | |
Feb 09, 2022 | fmr llc | - | 0 | SC 13G | |
Feb 08, 2022 | blackrock inc. | 9.0% | 127,917,655 | SC 13G/A | |
Feb 04, 2022 | wellington management group llp | 5.22% | 74,421,509 | SC 13G/A |
Date Filed | Form Type | Document | |
---|---|---|---|
Dec 07, 2023 | 4 | Insider Trading | |
Dec 04, 2023 | 4 | Insider Trading | |
Dec 04, 2023 | 4 | Insider Trading | |
Nov 22, 2023 | 8-K | Current Report | |
Nov 21, 2023 | 4 | Insider Trading | |
Nov 20, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 16, 2023 | 4 | Insider Trading | |
Nov 15, 2023 | 144 | Notice of Insider Sale Intent | |
Nov 09, 2023 | 4 | Insider Trading | |
Nov 07, 2023 | 4 | Insider Trading |
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
ABT | 181.9B | 40.0B | 9.79% | -0.70% | 35.24 | 4.55 | -11.26% | -34.57% |
BDX | 71.3B | 19.4B | -8.82% | -4.53% | 44.09 | 3.79 | 2.66% | -16.58% |
BAX | 18.3B | 15.0B | 6.81% | -29.70% | 7.06 | 1.22 | 3.01% | 209.09% |
ALGN | 16.9B | 3.8B | 9.66% | 15.63% | 46.7 | 4.45 | -1.48% | -28.97% |
MID-CAP | ||||||||
HSIC | 9.3B | 12.7B | 13.63% | -12.11% | 21 | 0.74 | 0.68% | -30.25% |
BIO | 8.9B | 2.7B | 2.35% | -23.26% | -55.55 | 3.25 | -3.01% | 97.36% |
ATR | 8.3B | 3.4B | 1.55% | 18.98% | 29.56 | 2.41 | 3.13% | 18.17% |
XRAY | 6.9B | 3.9B | 14.40% | 9.17% | -31.57 | 1.75 | -2.62% | 73.28% |
AXNX | 2.9B | 342.6M | 8.31% | -12.22% | -244.83 | 8.56 | 42.19% | 84.14% |
PDCO | 2.5B | 6.6B | -12.97% | -7.64% | 12.41 | 0.38 | 2.61% | 0.62% |
SMALL-CAP | ||||||||
AHCO | 1.1B | 3.1B | 3.77% | -63.31% | -2.53 | 0.35 | 7.95% | -550.16% |
ANIK | 329.0M | 163.3M | 7.10% | -27.48% | -13.39 | 2.01 | 7.14% | -56.09% |
ANGO | 282.7M | 335.9M | 6.52% | -42.04% | 43.86 | 0.84 | 4.71% | 116.39% |
APYX | 72.1M | 50.3M | -18.43% | 13.66% | -4.75 | 1.43 | 3.23% | 20.81% |
AEMD | 5.2M | 3.8M | 8.25% | -44.93% | -0.45 | 1.37 | 17.30% | 10.67% |
Income Statement (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Revenue | -2.0% | 3,527 | 3,599 | 3,389 | 3,242 | 3,170 | 3,244 | 3,026 | 3,127 | 2,932 | 3,077 | 2,752 | 2,709 | 2,659 | 2,003 | 2,543 | 2,904 | 2,707 | 2,631 | 2,493 | 2,561 | 2,393 |
Gross Profit | -4.6% | 2,426 | 2,542 | 2,349 | 2,232 | 2,191 | 2,233 | 2,071 | 2,155 | 2,032 | 2,132 | 1,858 | 1,709 | 1,790 | 1,212 | 1,737 | 2,054 | 1,930 | 1,873 | 1,763 | 1,833 | 1,720 |
Operating Expenses | -14.5% | 1,733 | 2,028 | 1,797 | 1,830 | 1,833 | 1,810 | 1,605 | 1,975 | 1,645 | 1,870 | 1,488 | 1,659 | 1,995 | 1,283 | 1,591 | 1,844 | 1,547 | 1,489 | 1,222 | 1,512 | 1,333 |
S&GA Expenses | -8.3% | 1,242 | 1,354 | 1,215 | 1,163 | 1,132 | 1,165 | 1,060 | 1,153 | 1,066 | 1,121 | 1,019 | 1,027 | 984 | 798 | 978 | 1,092 | 1,012 | 968 | 869 | 953 | 870 |
EBITDA Margin | -100.0% | - | 0.22* | 0.22* | 0.22* | 0.20* | 0.22* | 0.21* | 0.21* | 0.24* | 0.18* | 0.17* | 0.14* | 0.12* | 0.15* | 0.17* | - | - | - | - | - | - |
Interest Expenses | -5.7% | 66.00 | 70.00 | 65.00 | 64.00 | 63.00 | 64.00 | 279 | 87.00 | 86.00 | 86.00 | 82.00 | 96.00 | 86.00 | 91.00 | 88.00 | 180 | 95.00 | 89.00 | 109 | 65.00 | 58.00 |
Income Taxes | -32.7% | 105 | 156 | 131 | 256 | 57.00 | 85.00 | 45.00 | 26.00 | 64.00 | -37.00 | -16.00 | 96.00 | -72.00 | -33.00 | 12.00 | -4,002 | -35.00 | -9.00 | 33.00 | -90.00 | 24.00 |
Earnings Before Taxes | 43.2% | 610 | 426 | 444 | 396 | 245 | 345 | 156 | 119 | 483 | 149 | 325 | 307 | -227 | -181 | 22.00 | -6.00 | 91.00 | 145 | 457 | 296 | 456 |
EBT Margin | -100.0% | - | 0.11* | 0.11* | 0.09* | 0.07* | 0.09* | 0.07* | 0.09* | 0.11* | 0.05* | 0.02* | -0.01* | -0.04* | -0.01* | 0.02* | - | - | - | - | - | - |
Net Income | -100.0% | - | 270 | 314 | 140 | 188 | 260 | 110 | 95.00 | 419 | 186 | 341 | 210 | -155 | -147 | 11.00 | 3,996 | 126 | 154 | 424 | 386 | 432 |
Net Income Margin | -100.0% | - | 0.07* | 0.07* | 0.06* | 0.05* | 0.07* | 0.07* | 0.09* | 0.10* | 0.05* | 0.02* | -0.01* | 0.37* | 0.39* | 0.40* | - | - | - | - | - | - |
Free Cashflow | -100.0% | - | 515 | 79.00 | 595 | 320 | 202 | -179 | 212 | 358 | 537 | 209 | 514 | 594 | 201 | -177 | - | - | - | - | - | - |
Balance Sheet | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Assets | 1.3% | 34,043 | 33,601 | 32,892 | 32,469 | 31,947 | 32,189 | 32,337 | 32,229 | 31,877 | 31,168 | 30,900 | 30,777 | 30,845 | 30,823 | 30,113 | 30,565 | 26,756 | 24,309 | 23,802 | 20,999 | 20,379 |
Current Assets | 10.5% | 6,504 | 5,886 | 5,704 | 5,760 | 5,144 | 5,083 | 5,065 | 6,317 | 6,229 | 6,758 | 6,101 | 6,694 | 6,160 | 5,803 | 4,823 | 4,699 | 4,847 | 6,334 | 6,234 | 4,003 | 3,971 |
Cash Equivalents | 165.7% | 1,132 | 426 | 570 | 928 | 338 | 276 | 325 | 2,168 | 1,947 | 2,675 | 2,016 | 1,734 | 2,022 | 1,724 | 370 | 607 | 277 | 123 | 139 | 829 | 168 |
Inventory | 6.8% | 2,404 | 2,250 | 2,050 | 1,867 | 1,788 | 1,752 | 1,736 | 1,610 | 1,603 | 1,430 | 1,407 | 1,351 | 1,472 | 1,516 | 1,628 | 1,579 | 1,566 | 1,300 | 1,228 | 1,166 | 1,134 |
Net PPE | 4.0% | 2,635 | 2,534 | 2,478 | 2,446 | 2,273 | 2,246 | 2,265 | 2,252 | 2,109 | 2,082 | 2,053 | 2,084 | 2,064 | 2,079 | 2,098 | 2,079 | 1,942 | 1,820 | 1,782 | 1,782 | 1,730 |
Goodwill | -0.4% | 13,608 | 13,659 | 13,269 | 12,920 | 12,852 | 12,883 | 12,949 | 11,988 | 11,820 | 10,874 | 10,868 | 9,951 | 10,137 | 10,101 | 10,098 | 10,176 | 10,015 | 8,451 | 8,179 | 7,911 | 7,588 |
Current Liabilities | 0.4% | 4,579 | 4,562 | 4,083 | 3,803 | 3,549 | 3,883 | 4,275 | 4,274 | 4,022 | 4,073 | 3,393 | 3,681 | 3,302 | 3,108 | 3,976 | 4,866 | 4,254 | 4,850 | 4,479 | 5,260 | 5,082 |
Long Term Debt | -1.3% | 8,386 | 8,494 | 8,495 | 8,915 | 8,564 | 8,802 | 9,067 | 8,804 | 8,824 | 8,847 | 9,082 | 9,130 | 9,325 | 9,278 | 9,331 | 8,592 | 9,590 | 7,591 | 7,590 | 4,803 | 4,806 |
Shareholder's Equity | 3.6% | 18,886 | 18,226 | 17,850 | 17,573 | 17,640 | 17,251 | 16,735 | 16,622 | 16,462 | 15,942 | 15,719 | 15,326 | 15,564 | 15,616 | 13,804 | 13,877 | 9,699 | 9,425 | 9,233 | 8,726 | 8,289 |
Retained Earnings | 266.7% | 315 | -189 | -450 | -750 | -876 | -1,050 | -1,296 | -1,392 | -1,473 | -1,878 | -2,050 | -2,378 | -2,574 | -2,405 | -2,252 | -2,253 | -6,249 | -6,375 | -6,528 | -6,953 | -7,339 |
Additional Paid-In Capital | 0.6% | 20,573 | 20,441 | 20,356 | 20,289 | 20,219 | 20,103 | 20,043 | 19,986 | 19,930 | 19,817 | 19,750 | 19,732 | 19,687 | 19,590 | 17,589 | 17,561 | 17,510 | 17,422 | 17,374 | 17,346 | 17,304 |
Shares Outstanding | -100.0% | - | 1,446 | 1,436 | - | 1,432 | 1,430 | 1,428 | - | 1,424 | 1,421 | 1,419 | - | 1,431 | 1,411 | 1,397 | 1,395 | 1,393 | 1,391 | 1,388 | 1,385 | 1,383 |
Minority Interest | -6.2% | 243 | 259 | 259 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Cashflow (Quarterly) | (In Millions) | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Description | (%) Q/Q | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 |
Cashflow From Operations | 6.1% | 698 | 658 | 190 | 807 | 470 | 307 | -58.00 | 478 | 465 | 643 | 284 | 673 | 643 | 269 | -77.00 | 692 | 502 | 292 | 350 | 19.00 | 501 |
Share Based Compensation | -1.7% | 59.00 | 60.00 | 55.00 | 55.00 | 58.00 | 55.00 | 52.00 | 49.00 | 51.00 | 47.00 | 47.00 | 42.00 | 40.00 | 46.00 | 42.00 | 41.00 | 42.00 | 38.00 | 36.00 | 36.00 | 36.00 |
Cashflow From Investing | 76.5% | -197 | -840 | -484 | -183 | -225 | -29.00 | -1,574 | -461 | -1,207 | - | 71.00 | -147 | -129 | -59.00 | -76.00 | -49.00 | -3,962 | -620 | -410 | -595 | -662 |
Cashflow From Financing | -62.8% | 16.00 | 43.00 | -69.00 | 1.00 | -199 | -344 | -6.00 | -8.00 | 6.00 | 2.00 | -95.00 | -819 | -249 | 1,105 | 256 | -724 | 1,314 | 256 | 2,127 | 425 | 151 |
Dividend Payments | -100.0% | - | 14.00 | 14.00 | 13.00 | 14.00 | 14.00 | 14.00 | 13.00 | 14.00 | 14.00 | 14.00 | 14.00 | 14.00 | - | - | - | - | - | - | - | - |
Consolidated Statements of Operations (Unaudited) - USD ($) shares in Millions, $ in Millions | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Sep. 30, 2023 | Sep. 30, 2022 | Sep. 30, 2023 | Sep. 30, 2022 | |
Income Statement [Abstract] | ||||
Net sales | $ 3,527 | $ 3,170 | $ 10,515 | $ 9,440 |
Cost of products sold | 1,101 | 979 | 3,198 | 2,945 |
Gross profit | 2,426 | 2,191 | 7,317 | 6,495 |
Operating expenses: | ||||
Selling, general and administrative expenses | 1,242 | 1,132 | 3,811 | 3,357 |
Research and development expenses | 356 | 339 | 1,051 | 993 |
Royalty expense | 11 | 11 | 35 | 34 |
Amortization expense | 208 | 202 | 620 | 604 |
Intangible asset impairment charges | 1 | 125 | 58 | 132 |
Contingent consideration net expense (benefit) | 12 | 20 | 43 | 68 |
Restructuring net charges (credits) | 15 | 4 | 51 | 18 |
Litigation-related net charges (credits) | (111) | 0 | (111) | 42 |
Operating expenses | 1,733 | 1,833 | 5,558 | 5,248 |
Operating income (loss) | 693 | 358 | 1,759 | 1,247 |
Other income (expense): | ||||
Interest expense | (66) | (63) | (200) | (406) |
Other, net | (18) | (51) | (78) | (96) |
Income (loss) before income taxes | 610 | 245 | 1,480 | 745 |
Income tax expense (benefit) | 105 | 57 | 392 | 188 |
Net income (loss) | 504 | 188 | 1,088 | 558 |
Preferred stock dividends | 0 | (14) | (23) | (42) |
Net income (loss) attributable to noncontrolling interests | 0 | 0 | 0 | 0 |
Net income (loss) attributable to Boston Scientific common stockholders | $ 505 | $ 174 | $ 1,065 | $ 516 |
Net income (loss) per common share — basic | $ 0.34 | $ 0.12 | $ 0.74 | $ 0.36 |
Net income (loss) per common share — diluted | $ 0.34 | $ 0.12 | $ 0.73 | $ 0.36 |
Weighted-average shares outstanding | ||||
Basic | 1,464.5 | 1,431.6 | 1,448.8 | 1,429.7 |
Diluted | 1,475.0 | 1,440.0 | 1,459.1 | 1,438.7 |
Consolidated Balance Sheets (Unaudited) - USD ($) $ in Millions | Sep. 30, 2023 | Dec. 31, 2022 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 952 | $ 928 |
Trade accounts receivable, net | 2,101 | 1,970 |
Inventories | 2,404 | 1,867 |
Prepaid income taxes | 307 | 264 |
Other current assets | 741 | 731 |
Total current assets | 6,504 | 5,760 |
Property, plant and equipment, net | 2,635 | 2,446 |
Goodwill | 13,608 | 12,920 |
Other intangible assets, net | 5,849 | 5,902 |
Deferred tax assets | 3,840 | 3,942 |
Other long-term assets | 1,605 | 1,500 |
TOTAL ASSETS | 34,043 | 32,469 |
Current liabilities: | ||
Current debt obligations | 513 | 20 |
Accounts payable | 929 | 862 |
Accrued expenses | 2,255 | 2,160 |
Other current liabilities | 882 | 761 |
Total current liabilities | 4,579 | 3,803 |
Long-term debt | 8,386 | 8,915 |
Deferred income taxes | 91 | 144 |
Other long-term liabilities | 1,858 | 2,035 |
Commitments and contingencies | ||
Stockholders’ equity | ||
Preferred stock, $0.01 par value - authorized 50,000,000 shares - 0 shares issued as of September 30, 2023 and 10,062,500 shares as of December 31, 2022 | 0 | 0 |
Common stock, $0.01 par value - authorized 2,000,000,000 shares - issued 1,728,158,524 shares as of September 30, 2023 and 1,696,633,993 shares as of December 31, 2022 | 17 | 17 |
Treasury stock, at cost - 263,289,848 shares as of September 30, 2023 and December 31, 2022 | (2,251) | (2,251) |
Additional paid-in capital | 20,573 | 20,289 |
Retained earnings/(Accumulated deficit) | 315 | (750) |
Accumulated other comprehensive income (loss), net of tax | 231 | 269 |
Total stockholders’ equity | 18,886 | 17,573 |
Noncontrolling interests | 243 | 0 |
Total equity | 19,129 | 17,573 |
TOTAL LIABILITIES AND EQUITY | $ 34,043 | $ 32,469 |
 CEO | Mr. Michael F. Mahoney |
---|---|
 WEBSITE | www.bostonscientific.com |
 EMPLOYEES | 45000 |